These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26806461)

  • 21. [Successful remission induction with reduced-dose all-trans retinoic acid for acute promyelocytic leukemia complicated by COVID-19].
    Fujimoto R; Kamae T; Kamijo K; Yasumi M; Karasuno T
    Rinsho Ketsueki; 2024; 65(6):498-501. PubMed ID: 38960647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down syndrome with microgranular variant of acute promyelocytic leukemia in a child: a case report.
    Jain D; Singh T; Arora P
    J Med Case Rep; 2007 Nov; 1():147. PubMed ID: 18036234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapies for newly diagnosed acute promyelocytic leukemia].
    Yokoyama Y
    Rinsho Ketsueki; 2020; 61(9):1166-1173. PubMed ID: 33162512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed recovery of normal hematopoiesis in arsenic trioxide treatment of acute promyelocytic leukemia: a comparison to all-trans retinoic acid treatment.
    Shinjo K; Takeshita A; Sahara N; Kobayashi M; Nakamura S; Shigeno K; Naito K; Maekawa M; Ohnishi K; Ohno R
    Intern Med; 2005 Aug; 44(8):818-24. PubMed ID: 16157979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute promyelocytic leukemia in childhood.
    Gregory J; Feusner J
    Curr Oncol Rep; 2009 Nov; 11(6):439-45. PubMed ID: 19840521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arsenic trioxide as first-line treatment for acute promyelocytic leukemia.
    Leu L; Mohassel L
    Am J Health Syst Pharm; 2009 Nov; 66(21):1913-8. PubMed ID: 19850784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells.
    Shao W; Fanelli M; Ferrara FF; Riccioni R; Rosenauer A; Davison K; Lamph WW; Waxman S; Pelicci PG; Lo Coco F; Avvisati G; Testa U; Peschle C; Gambacorti-Passerini C; Nervi C; Miller WH
    J Natl Cancer Inst; 1998 Jan; 90(2):124-33. PubMed ID: 9450572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia.
    Agis H; Weltermann A; Mitterbauer G; Thalhammer R; Edelhäuser M; Seewann HL; Valent P; Lechner K; Fonatsch C; Geissler K
    Ann Hematol; 1999 Jul; 78(7):329-32. PubMed ID: 10466445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
    Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
    Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hand-mirror variant of microgranular acute promyelocytic leukemia.
    Sun T; Weiss R
    Leukemia; 1991 Mar; 5(3):266-9. PubMed ID: 2013982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of a case of relapsed acute promyelocytic leukemia with arsenic trioxide.
    Hirayama Y; Koyama R; Nagai T; Ohta H; Kondo A; Ishikawa K; Ishitani K; Matsunaga T; Sakamaki S; Niitsu Y
    Intern Med; 2001 Nov; 40(11):1136-9. PubMed ID: 11757771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute promyelocytic leukemia: a curable disease.
    Lo Coco F; Nervi C; Avvisati G; Mandelli F
    Leukemia; 1998 Dec; 12(12):1866-80. PubMed ID: 9844917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
    J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical blasts and bone marrow necrosis associated with near-triploid relapse of acute promyelocytic leukemia after arsenic trioxide treatment.
    Chim CS; Lam CC; Wong KF; Man C; Kam S; Kwong YL
    Hum Pathol; 2002 Aug; 33(8):849-51. PubMed ID: 12203219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical and laboratory features of patients with CD34(+) acute promyelocytic leukemia].
    Liang JY; Wu DP; Liu YJ; Ma QF; Xue YQ; Zhu MQ; Chen ZX
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):196-8. PubMed ID: 19615259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Provocative pearls in diagnosing and treating acute promyelocytic leukemia.
    Stein EM; Tallman MS
    Oncology (Williston Park); 2012 Jul; 26(7):636-41. PubMed ID: 22888564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [State-of-the-art treatment of acute promyelocytic leukemia].
    Kiguchi T
    Rinsho Ketsueki; 2018; 59(10):2007-2018. PubMed ID: 30305503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute promyelocytic leukemia as a paradigm for targeted therapy.
    Tallman MS
    Semin Hematol; 2004 Apr; 41(2 Suppl 4):27-32. PubMed ID: 15190513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Complete remission of acute promyelocytic leukemia accompanied by DIC in an elderly patient treated with all-trans retinoic acid].
    Handa H; Jinbo T; Okamoto K; Hirabayashi H; Miyawaki S
    Nihon Ronen Igakkai Zasshi; 1993 Feb; 30(2):146-9. PubMed ID: 8483289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.